Methotrexate at middle and high accumulative doses might be associated with lower risk of new-onset cancers in patients with rheumatoid arthritis: a nationwide population-based cohort study. (IF: 5.35; SCIE: Q1)
Methotrexate at middle and high accumulative doses might be associated with lower risk of new-onset cancers in patients with rheumatoid arthritis: a nationwide population-based cohort study. (IF: 5.35; SCIE: Q1)
| Year | 2020 |
| Author | 彭武村 |
| Author count | 1 |
| Created date | 2021-09-11 |
| Author order | 第一作者 |
| Corresponding author | 否 |
| Publication year | 2020 |
| Publication month | 12 |
| Journal name | Therapeutic Advances in Musculoskeletal Disease (Ther Adv Musculoskelet Dis) |
| Publication area | 美國 |
| Volume | 12 |
| Issue | 0 |
| Start page | 1 |
| End page | 12 |
| Publication type | |
| Review system | 是 |
| Language | Foreign Language |